Active ingredientBevantololCat. No. P-B069-001CAS 59170-23-9Family · Pharmaceutical analytical standards
Bevantolol
A beta-1 selective beta blocker that also blocks alpha-1 receptors and calcium channels: studied in the 1980s for angina and hypertension, it was approved in Japan in 1995. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?In the United States the application for approval was withdrawn in 1989: the chairman of the company that developed it remarked "Who needs the 30th beta blocker?".
Go to the active ingredient →Active ingredientBevantololCat. No. P-B069-001CAS 59170-23-9
Active ingredientBevantolol HClCat. No. P-B069-002CAS 42864-78-8
NitrosamineN-Nitroso BevantololCat. No. P-B069-004![2-[(2-Ethylphenoxy)methyl]oxirane](https://img.vitasanlabs.com/vsl-struct/P-B069-005.svg?v=41e934f030)
Impurity2-[(2-Ethylphenoxy)methyl]oxiraneCat. No. P-B069-005CAS 15620-78-7
ImpurityBevantolol Impurity 1Cat. No. P-B069-007CAS 204584-12-3
ImpurityBevantolol Impurity 2Cat. No. P-B069-008CAS 175157-64-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.